ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000257410.1	ABT-263 (navitoclax)	Chronic Lymphocytic Leukemia	0.022219557	Resistant
ENSG00000257410.1	ABT-263 (navitoclax)	Sarcoma	0.013138436	Resistant